Reference sequence (1): human-PNLIP Identities normalised by aligned length. Colored by: consensus/70% and property |
1 human-PNLIP 100.0% --------------MLPLWTLSL-LLGAVAGKEVCYERLGCFSDDSPWS-GITERPLHILPWSPKDVNTRFLLYTNENPNNFQEVAA-DSSSISGSNFKTNRKTRFIIHGFIDKGEENWL 2 spetr-1plip 84.7% --------------MLLVWSLAL-LLGAVAGKEVCYDRLGCFSDDSPWS-GIVERPLKVLPWSPADVNTRFFLYTNENQDNYQQITA-DSSRIQSSNFKTNRKTRFIIHGFIDKGEESWL 3 sussc-1plip 85.3% -------------------------------SEVCFPRLGCFSDDAPWA-GIVQRPLKILP-PDKDVDTRFLLYTNQNQNNYQELVA-DPSTITNSNFRMDRKTRFIIHGFIDKGEEDWL 4 horse-1plip 83.3% ------------------WTLSL-LLGAVVGNEVCYERLGCFSDDSPWA-GIVERPLKILPWSPEKVNTRFLLYTNENPDNFQEIVA-DPSTIQSSNFNTGRKTRFIIHGFIDKGEESWL 5 myoco-1plip 79.2% ----------------------L-LLGAVAGSEVCYDRLGCFSDDSPWA-GIVERPLKVLPWSPSTINTRFLLYTNESPNNYQIVTA-DSSTIRSSNFRTDRKTRFIIHGYIDKGEENWL 6 mouse-1plip 78.5% --------------MLMLWTFAV-LLGAVAGREVCFDKLGCFSDDAPWS-GTLDRPLKALPWSPAQINTRFLLYTNENPDNYQLITS-DASNIRNSNFRTNRKTRIIIHGFIDKGEENWL 7 ratno-1plip 78.1% --------------MLMLWTFAV-LLGAVAGKEVCFDKLGCFSDDAPWS-GTIDRPLKALPWSPAQINTRFLLYTNENQDNYQKITS-DASSIRNSNFKTNRKTRIIIHGFIDKGEENWL 8 cavpo-1plip 75.9% --------------MLLLWILSL-FLETVAGGEVCFDRLGCFSDNKPWA-GTSERPRKGLPWDPSAINVRFLLYTNENPNNYQRITA-DSSVIRSSDFKTDRKTRFIIHGFIDKGEENWL 9 rabit-1plip 79.6% --------------MLLLWALPL-LLGAVAGLEVCYERLGCFGNRIPWSGGTLERPFSTLPSTPKIVNTRFLLYTNENPNNFQEISA-DASTIRGSNFRTDRKTRFIIHGFTDKGEENWL 10 human-PNLIPRP1 67.1% --------------MLIFWTITLFLLGAAKGKEVCYEDLGCFSDTEPWG-GTAIRPLKILPWSPEKIGTRFLLYTNENPNNFQILLLSDPSTIEASNFQMDRKTRFIIHGFIDKGDESWV 11 canfa-1plip 68.4% --------------MVSIWTIALFLLGAAKAKEVCYEQIGCFSDAEPWA-GTAIRPLKVLPWSPERIGTRFLLYTNKNPNNFQTLLPSDPSTIEASNFQTDKKTRFIIHGFIDKGEENWL 12 mouse-1plrp 65.8% --------------MLILWTIPLFLLGAAQGKEVCYDNLGCFSDAEPWA-GTAIRPLKLLPWSPEKINTRFLLYTNENPTAFQTLQLSDPSTIEASNFQVARKTRFIIHGFIDKGEENWV 13 ratno-3plip 66.5% --------------MLTLWTVSLFLLGAAQGKEVCYDNLGCFSDAEPWA-GTAIRPLKLLPWSPEKINTRFLLYTNENPTAFQTLQLSDPLTIGASNFQVARKTRFIIHGFIDKGEENWV 14 human-PNLIPRP2 64.0% --------------MLPPWTLGLLLLATVRGKEVCYGQLGCFSDEKPWA-GTLQRPVKLLPWSPEDIDTRFLLYTNENPNNFQLITGTEPDTIEASNFQLDRKTRFIIHGFLDKAEDSWP 15 ratno-4plip 65.6% MPRGVSGNLFPSVQMLLCWIVSL-LLATVGGKEVCYGHLGCFSNDKPWA-GMLQRPLKIFPWSPEDIDTRFLLYTNENPNNYQKISATEPDTIKFSNFQLDRKTRFIVHGFIDKGEDGWL 16 mouse-cttli 66.2% --------------MLLCWLVSL-LLATVGGKEVCYGHLGCFSNDKPWA-GMIQRPSKIFPWSPEDIDTRFLLYTNENPNNYQIISATDPATINASNFQLDRKTRFIIHGFIDKGEEGWL 17 bovin-lipr2 61.2% --------------MLPSWTIGLLLLATVRGKEICYEPFGCFSDEKPWT-GILQRPLKLFPWSPEDIDAHFLLYTNENPNNYQRINITDLATVRASNFQLDRKTRFVIHGFIDDGDSGWP 18 myoco-2plrp 63.0% -------------MMLFVWTTGLLLLATARGNEVCYSHLGCFSDEKPWA-GTLQRPVKSLPASPESINTRFLLYTNENPNNYQLITATDPATIKASNFNLHRKTRFVIHGFIDNGEKDWL 19 horse-2plrp 57.7% -------------------------------KEVCYTPLGCFSDDKPWA-GTLQRPLKSLPWSPEEVNTRFLLYTNKNPDSYQLITARDVATIKSSNFQSSRKTHFVIHGFRDRGEDSWP 20 xenla-q4klb6 65.2% -------------MISGLWLVAL-LLGAAKGGEVCYSRIGCFPDSVPWS-GTVERPINHLPQSPEKINTRFLLFTQQNSNSFQEISAINPSTISSSNFRTNRKTRFIIHGFIDKGEESWL 21 xenla-q642r3 53.4% --------------MSGCWGLIFFLLGYVQAGKVCYDKIGCFTDDKPWS-GTLERLIGRLPESPEHINTHLLMFTRENPDMFQELHSLNPSALPLTNFKTNRKSRFIIHGFLEQGEENWL 22 xentr-q6p2z1 55.1% --------------MLGLWGLFFFLLGCVQGEPVCYDKIGCFSDEKPWS-GTLERPIARLPSSPEHINTRLLLFTRENAENFQELRPLNPSAVSLTNFKTSRKSRFIIHGFIDEGEENWL 23 xentr-q5eb42 52.6% --------------MLEILGLILLTSGFVQGGQVCYERIGCFPDEAPWG-GTVQRPIARLPDSPEHINTRFLLFTKENPDTFQEIRALTPGAISTSNFKASRKTRFIIHGFIEHGYDRWL 24 angja-1plip 57.7% -------------MMSVVWILGLFLLGTASGAEVCYENLGCFTDDVPWA-GTTERPIAKLPWSPEKIGTRFMLFTRQNPNNHQEITT-KEDILLASNYNGTRKTRFITHGYVDKGDENWL 25 xenla-q6pad5 45.5% M---LSAD-IPL-CQLLILIILHGIFGTVKGKEICYEPFGCFSDKQPWS-RTKERPFAALPWTPESINTRFFLNTRRNPNQHQIISAQNITSIEASAFQTNQTTCFIVHGMGERAENNWV 26 human-PNLIPRP3 46.7% --------------MLGIWIVAFLFFGTSRGKEVCYERLGCFKDGLPWT-RTFSTELVGLPWSPEKINTRFLLYTIHNPNAYQEISAVNSSTIQASYFGTDKITRINIAGW--KTDGKWQ consensus/100% .................................lCa..hGCF.st.PWs.th..p....hP.sst.lss+hhh.T.ps.p.aQ.l...p...l..o.at.tphoph.htGh..ps.ttW. consensus/90% ......................h.h.ths.utcVCat.lGCFsst.PWu.Ghh.RPhthhP.oPtplsTRFhLaTppN.ssaQ.l...p.sslt.SsFphs+KTRhllHGah-cu-psW. consensus/80% ..............h...Whh.h.lLusstGtEVCYpplGCFoDptPWu.GhhpRPlthLP.SPcplsTRFLLaTpcNPssaQ.lps.ssusIpsSNFphsRKTRFIIHGFlD+GE-sWl consensus/70% ..............Ml.hWhlsl.LLusstGpEVCY-pLGCFSDctPWu.GhhpRPlphLPWSPccIsTRFLLYTNENPssaQ.lsu.-suoIpuSNFpssRKTRFIIHGFIDKGE-sWl 1 human-PNLIP 100.0% ANVCKNLFKVESVNCICVDWKGGSRT--GYTQASQNIRIVGAEVAYFVEFLQSAFGYSPSNVHVIGHSLGAHAAGEAGRRTNGTIGRITGLDPAEPCFQGTPELVRLDPSDAKFVDVIHT 2 spetr-1plip 84.7% ANMCKKMFQVESVNCICVDWKGGSRT--GYTQASQNIRIVGAEVAYFVDFLRTQLGYSPSNVHVIGHSLGSHAAGEAGRRTNGAIGRITGLDPAEPCFEGTPELVRLDPSDAQFVDAIHT 3 sussc-1plip 85.3% SNICKNLFKVESVNCICVDWKGGSRT--GYTQASQNIRIVGAEVAYFVEVLKSSLGYSPSNVHVIGHSLGSHAAGEAGRRTNGTIERITGLDPAEPCFQGTPELVRLDPSDAKFVDVIHT 4 horse-1plip 83.3% STMCQNMFKVESVNCICVDWKSGSRT--AYSQASQNVRIVGAEVAYLVGVLQSSFDYSPSNVHIIGHSLGSHAAGEAGRRTNGAVGRITGLDPAEPCFQGTPELVRLDPSDAQFVDVIHT 5 myoco-1plip 79.2% ANMCEALLQVESVNCICVDWKGGSRA--LYTQATQNIRVVGAEVAYFVDALQSQLGYSPSNVHIIGHSLGSHVAGEAGRRTNGNIGRITGLDPAEPCFQGTPELVRLDPSDAQFVDVIHT 6 mouse-1plip 78.5% SDMCKNMFRVESVNCICVDWKGGSRT--TYTQATQNVRVVGAEVALLVNVLQSDLGYSLNNVHLIGHSLGSHIAGEAGKRTFGAIGRITGLDPAEPYFQGTPEEVRLDPTDAQFVDAIHT 7 ratno-1plip 78.1% SDMCKNMFKVESVNCICVDWKGGSRA--TYTQATQNVRVVGAEVALLVNVLKSDLGHPPDNVHLIGHSLGSHVAGEAGKRTFGAIGRITGLDAAEPYFQGTPEEVRLDPTDAQFVDAIHT 8 cavpo-1plip 75.9% ADLCKALFQVESVNCICVDWRGGSRT--LYSQASQNIQVVGAEVAYLINFLQSQLDYPPSSVHIIGHSLGSHAAGEAGRRTNGAIGRITGLDPAEPYFQYTPEIVRLDPSDAQFVDVIHT 9 rabit-1plip 79.6% SNLCENLFQVETVNCICVDWKGGSRT--TYPQATQNIRIVGAEVAYLVGTLQSSLGYSPSNIHVIGHSLGAHAAGEVGRRTNGTIGRITGLDPAEPYFQGTPEIVRLDPSDAQFVDVIHT 10 human-PNLIPRP1 67.1% TDMCKKLFEVEEVNCICVDWKKGSQA--TYTQAANNVRVVGAQVAQMLDILLTEYSYPPSKVHLIGHSLGAHVAGEAGSKTPG-LSRITGLDPVEASFESTPEEVRLDPSDADFVDVIHT 11 canfa-1plip 68.4% LDMCKNMFKVEEVNCICVDWKKGSQT--SYTQAANNVRVVGAQVAQMLSMLSANYSYSPSQVQLIGHSLGAHVAGEAGSRTPG-LGRITGLDPVEASFQGTPEEVRLDPTDADFVDVIHT 12 mouse-1plrp 65.8% VDMCKNMFQVEEVNCICVDWKRGSQT--TYTQAANNVRVVGAQVAQMIDILVRNFNYSASKVHLIGHSLGAHVAGEAGSRTPG-LGRITGLDPVEANFEGTPEEVRLDPSDADFVDVIHT 13 ratno-3plip 66.5% VDMCKNMFQVEEVNCICVDWKKGSQT--TYTQAANNVRVVGAQVAQMIDILVKNYSYSPSKVHLIGHSLGAHVAGEAGSRTPG-LGRITGLDPVEANFEGTPEEVRLDPSDADFVDVIHT 14 human-PNLIPRP2 64.0% SDMCKKMFEVEKVNCICVDWRHGSRA--MYTQAVQNIRVVGAETAFLIQALSTQLGYSLEDVHVIGHSLGAHTAAEAGRRLGGRVGRITGLDPAGPCFQDEPEEVRLDPSDAVFVDVIHT 15 ratno-4plip 65.6% LDMCKKMFQVEKVNCICVDWRRGSRT--EYTQASYNTRVVGAEIAFLVQVLSTEMGYSPENVHLIGHSLGAHVVGEAGRRLEGHVGRITGLDPAEPCFQGLPEEVRLDPSDAMFVDVIHT 16 mouse-cttli 66.2% LDMCKKMFQVEKVNCICVDWKRGSRT--EYTQASYNTRVLGAEIAFLVQVLSTEMGYSPENVHLIPHSLGSHVAGEAGRRLEGHVGRITGLDPAEPCFQGLPEEVRLDPSDAMFVDVIHT 17 bovin-lipr2 61.2% TDLCKKMFKVEKVNCICVDWEHGAWT--KYTQAVHNTRVVGAEIAFFIQGLSTELGYGPENVHLIGHSLGAQLAAEAGRRLGGQVGRITGLDPAQPCFEGTPEEVRLDPSDAMFVDVIHT 18 myoco-2plrp 63.0% TDICKRMFQVEKVNCICVDWQGGSLA--IYSQAVQNIRVVGAEVAYLVQVLSDQLGYKPGNVHMIGHSLGAHTAAEAGRRLKGLVGRITGLDPAEPCFQDTPEEVRLDPSDAMFVDVIHT 19 horse-2plrp 57.7% SDMCKKILQVETTNCISVDWSSGAKA--EYTQAVQNIRIVGAETAYLIQQLLTELSYNPENVHIIGHSLGAHTAGEAGRRLEGRVGRVTGLDPAEPCFQDASEEVRLDPSDAQFVDVIHT 20 xenla-q4klb6 65.2% TDMCKTMLQVEDVNCFCVDWMGGSRT--LYTQASNNIRVVGAEVAYFIDILSSTYGYSPANVHVIGHSLGAQAAGEAGKRRKG-IGRITGLDPAEPYFQGTPTEVRLDPSDANFVDVIHT 21 xenla-q642r3 53.4% VNMCKTMLKVEDVNCFCVDWSGGSRT--LYSQAANNIRVVGAELAYFISFLSNNMNYSLSKVHVIGHSLGSHTAGEVGKRVPG-IGRITGLDPAGPFFQDTPPEVRLDPTDALFVDVIHT 22 xentr-q6p2z1 55.1% VNMCKAMLKVEDVNCFCTDWSGGSRT--IYTQAANNIRVVGAELAYFIGYLSSKMKYPLSNVHIIGHSLGSHTAGEVGKRMPG-IGRITGLDPAGPYFQNTPIEVRLDPTDAVFVDAIHT 23 xentr-q5eb42 52.6% THMCATLLKVEDVNCFCVDWTGGAYA--LYSQAANNVRVVGAEVAHFIQFLSNQYGYSAANVHVIGHSLGSHAAGETGKRTPG-IARITGLDPAGPFFQNTPPEVRLDQSDAQLVDVIHT 24 angja-1plip 57.7% IDMCKLMLQVEDINCICVDWKKGGRT--LYTQSASNIRVIGAQMAYMIQLFQKVYQQRPESVHIIGHSLGAHCAGEAGRRTPN-LGRITGLDPAEPYFQGCPSLVRLDPSDAKFVDVIHT 25 xenla-q6pad5 45.5% SQMCKAILQVEDVNCIGVDWRNGSGNIQMYVQAANNIRVVGAEIALLLQVLQKELGYPASKVHVIGHSLGAHAAGEAGRRHEG-IWRITGLDPARQFFEDTPPEVRLDPSDATFVDVIHT 26 human-PNLIPRP3 46.7% RDMCNVLLQLEDINCINLDWINGSRE---YIHAVNNLRVVGAEVAYFIDVLMKKFEYSPSKVHLIGHSLGAHLAGEAGSRIPG-LGRITGLDPAGPFFHNTPKEVRLDPSDANFVDVIHT consensus/100% .phCt.hhplEphNChshDW.tGu.t...Y.pus.NhpllGAphA.hlt.h.t.ht...tplphIsHSLGuphsuEsGp+h.s.l.RlTGLDsst..Fp..s..VRLD.oDA.hVDsIHT consensus/90% .shCpthhpVEplNChsVDWptGu.s...YsQAspNhRlVGAphA.hlthL.pphtYs.tpVHlIGHSLGuHhAuEsGpRh.G.luRITGLDPsts.FpstP..VRLDPoDA.FVDsIHT consensus/80% sshCKthhpVEpVNCICVDWptGSps..hYoQAspNlRlVGAElAhhlphLpsphsYssppVHlIGHSLGuHsAGEAG+Rh.G.lGRITGLDPApPhFpsTPp.VRLDPSDA.FVDVIHT consensus/70% ssMCKphhpVEpVNCICVDWctGSps..hYoQAspNlRVVGAElAahlphLpsphuYsPssVHlIGHSLGuHsAGEAG+Rh.G.lGRITGLDPAEPhFQsTPE.VRLDPSDApFVDVIHT 1 human-PNLIP 100.0% DGAPIVPNLGFGMSQVVGHLDFFPNGGVEMPGCKKNILSQI-VDIDGIWEGTRDFAACNHLRSYKYYTDSIVNPDGFAGFPCASYNVFTANKCFPCPSGGCPQMGHYADRYPGKTNDV-G 2 spetr-1plip 84.7% DGAPIVPNLGFGMSQTVGHLDFFPNGGIEMPGCQKNILSQI-VDIDGIWEGTRDFAACNHLRSYKYYTDSIVNPTGFAAFSCASYSVFSANKCFPCPSGGCPQMGHYADRYSGKTNGV-G 3 sussc-1plip 85.3% DAAPIIPNLGFGMSQTVGHLDFFPNGGKQMPGCQKNILSQI-VDIDGIWEGTRDFVACNHLRSYKYYADSILNPDGFAGFPCDSYNVFTANKCFPCPSEGCPQMGHYADRFPGKTNGV-S 4 horse-1plip 83.3% DIAPFIPNLGFGMSQTAGHLDFFPNGGKEMPGCQKNVLSQI-VDIDGIWQGTRDFAACNHLRSYKYYTDSILNPDGFAGFSCASYSDFTANKCFPCSSEGCPQMGHYADRFPGRTKGV-G 5 myoco-1plip 79.2% DGAPIIPNLGFGMSQTVGHLDFFPNGGVEMPGCQKNIISQI-VDINGIWEGTRDFAACNHLRSYKYYIDSILNPTGFAGFSCSSYNTFSSNNCFPCASGGCPQMGHYADRFSGKTNEL-F 6 mouse-1plip 78.5% DAGPIIPNLGFGMSQTVGHLDFFPNGGIEMPGCQKNILSQI-VDIDGIWEGTRNFAACNHLRSYKFYTDSIVNPTGFAGFSCSSYSLFTANKCFPCGSGGCPQMGHYADRYPGKTSRL-Y 7 ratno-1plip 78.1% DAAPIIPNLGFGMSQTVGHLDFFPNGGMEMPGCQKNILSQI-VDIDGIWEGTRDFAACNHLRSYKYYTDSIVNPTGFSGFSCSSYNVFSANKCFPCGSEGCPQMGHYADKYPGKTKEL-Y 8 cavpo-1plip 75.9% DGNPIIPNLGFGMSQTVGHLDFFPNGGLQMPGCQKNILSQI-VDIDGIWEGTRDFAACNHLRSYKYYIDSITNPKGFAGFSCDSYSSFSSNKCFPCATGECPQMGHYADKFPGKTKEN-F 9 rabit-1plip 79.6% DAAPMVPNLGFGMSQTVGHLDFFPNGGKEMPGCQKNVLSQI-VDINGVWEGTRDFVACNHLRSYKYYADSIVNPNGFAGFSCASYTAFSANKCFPC-SNGCPQMGHYADRFSRKTDGV-G 10 human-PNLIPRP1 67.1% DAAPLIPFLGFGTNQQMGHLDFFPNGGESMPGCKKNALSQI-VDLDGIWAGTRDFVACNHLRSYKYYLESILNPDGFAAYPCTSYKSFESDKCFPCPDQGCPQMGHYADKFAGRTSEE-Q 11 canfa-1plip 68.4% DAAPLIPFLGFGTSQQMGHLDFFPNGGEEMPGCKKNALSQI-VDLDGIWEGTRDFVACNHLRSYKYYSESILNPDGFASYPCASYRAFESNKCFPCPDQGCPQMGHYADKFAVKTSDE-T 12 mouse-1plrp 65.8% DAAPLIPFLGFGTNQMVGHFDFFPNGGQYMPGCKKNALSQI-VDIDGIWSGTRDFVACNHLRSYKYYLESILNPDGFAAYPCASYRDFESNKCFPCPDQGCPQMGHYADKFANNTSVE-P 13 ratno-3plip 66.5% DAAPLIPFLGFGTNQMSGHLDFFPNGGQSMPGCKKNALSQI-VDIDGIWSGTRDFVACNHLRSYKYYLESILNPDGFAAYPCASYKDFESNKCFPCPDQGCPQMGHYADKFAGKSGDE-P 14 human-PNLIPRP2 64.0% DSSPIVPSLGFGMSQKVGHLDFFPNGGKEMPGCKKNVLSTI-TDIDGIWEGIGGFVSCNHLRSFEYYSSSVLNPDGFLGYPCASYDEFQESKCFPCPAEGCPKMGHYADQFKGKTSAV-E 15 ratno-4plip 65.6% DSAPIIPYLGFGMSQKVGHLDFFPNGGKEMPGCQKNILSTI-VDINGIWEGTQNFVACNHLRSYKYYASSILNPDGFLGYPCSSYEKFQQNDCFPCPEEGCPKMGHYADQFEGKTATV-E 16 mouse-cttli 66.2% DSAPIIPYLGFGMSQKVGHLDFFPNGGKEIPGCQKNILSTI-VDINGIWEGTRNFAACNHLRSYKYYASSILNPDGFLGYPCSSYEKFQHNDCFPSPEQGCPKMGHYADQFEGKTATV-E 17 bovin-lipr2 61.2% DSASIIPFLSLGIRQKVGHLDFYPNGGKEMPGCQKNILSTI-IDINGIWQGIQDFVACSHLRSYKYYSSSILNPDGFLGYPCASYEEFQEGGCFPCPAGGCPKMGHYADQFQGKTSAV-G 18 myoco-2plrp 63.0% DIAPIIPSFGFGMSQKVGHMDFFPNGGKEMPGCEKNIISTI-VDVNGFLEGITSLAACNHMRSYQYYSSSILNPDGFLGYPCASYEEFQKDGCFPCPAEGCPKMGHYADQFQGKANGV-E 19 horse-2plrp 57.7% DASPMLPSLGFGMSQKVGHMDFFPNGGKQMPGCKRSSFSTF-IDINGIWQGAQDYLACNHLKSFEYYSSSILNPDGFLAYPCDSYDKFQENGCFPCPAGGCPKMGHYADQYKEKTSAV-E 20 xenla-q4klb6 65.2% DAAPMIPNLGLGMSQLAGHLDFFPNGGEEMPGCKKNALSQI-VDIDGIWQGTRDFVACNHLRSYKYYSNSILKRDGFVGYPSSTYNTFKTGSVFPCPSGGCPLMGHYADTYKGPITG--G 21 xenla-q642r3 53.4% DTSPLIPKMGYGMRQSVGHMDFFPNGGESMRGCNKPIVAKL-LDIDGLWEGSRDIFACNHLRSYKYYTESITSPNGFIGYPSTSYGEFTKGNGFPCPSSGCPLMGHYADLFSGHGIN--E 22 xentr-q6p2z1 55.1% DTDPLIPKMGYGMSQSVAHMDFFPNGGENMPGCSKPILAKL-LDIDGLWEGSKDIFACNHLRSYKYYTESISSPDGFVGYPSTSYEAFTKGTGFPCPTTGCPLMGHYADAFSSHGTS--D 23 xentr-q5eb42 52.6% DASAIFPLTGFGIGQSVGHLDFYPNGGKNMPGCKKSPTLKY-LDNYRIFKGSKEIIFCSHIRSYKFYTESILTPDAFVAFPSSDYKTFKKGTGFPCPSGGCPLMGHYAEEFLGPTSG--N 24 angja-1plip 57.7% DAKPMIPYLGMGMAQAVGHLDFYPNGGEHMPGCDKNIISQT-VDIDGIWEGTRDFVACNHLRSYKYYSDSILNPEGFTGYPCSDGGVFESGRCFPCGDGACPFMGHHADKFRRPNGAE-K 25 xenla-q6pad5 45.5% DIS---SPLGAGIAKPIGHLDFYPNGGKQMTGCPAK------LSFLGNFNALFDTMTCSHFRAFQYYTESLRSPGGFLGYPCESYDSFLSGSCFPCPEGRCSLMGHFS-RLPSALTAT-P 26 human-PNLIPRP3 46.7% NAARILFELGVGTIDACGHLDFYPNGGKHMPGCEDLITPLLKFNFNAYKKEMASFFDCNHARSYQFYAESILNPDAFIAYPCRSYTSFKAGNCFFCSKEGCPTMGHFADRFHFKNMKTNG consensus/100% s.t.....huhGh.p..uHhDFaPNGG..h.GC.t.......hs..t.htt..thh.CsHh+uapaY.pSl.p.tuF.uasstsht.F.tstsF.s.tttCs.MGHau..h......... consensus/90% D.sshlP.hGhGhtQ.hGHhDFaPNGG.pMPGCp+s.hsph.lDhsGhapG.tshhsCsHhRSapaY.pSIhsPsGFhuasssoYp.FptstsFPCsttuCP.MGHaADpa.t.stt... consensus/80% DuuPhlP.LGaGhsQtsGHLDFFPNGG.pMPGCpKshlSpl.lDlsGlWpGspsahACNHLRSYKYYspSIlNPsGFhuasCsSYp.FptspCFPCsstGCP.MGHYADpa.s+sst... consensus/70% DuuPllP.LGFGhuQpVGHLDFFPNGGppMPGCpKNhlSpI.lDIsGIWpGo+DFsACNHLRSYKYYs-SIlNPcGFhuaPCsSYptFptspCFPCsstGCPpMGHYADpF.u+oss..t 1 human-PNLIP 100.0% QKFYLDT-GDASNFARWRYKVSVTLSGK-K--VTGHILVSLFGNKGNSKQYEIFKGTLKPDSTHSNEFDSDVDVGDLQMVKFIWY-NNVINPTLPRVGASKIIVET-NVGKQFNFCSPET 2 spetr-1plip 84.7% QKFYLNT-GDKNNFSRLRYKVSVTLSGQ-K--VTGHILVSLFGNAGNSQQYEIYKGSLHPGYTHSNEFDSDVDVGDLQRVKFIWY-NNVINPSLPRMGASSISVER-NDGRVFKFCSAET 3 sussc-1plip 85.3% QVFYLNT-GDASNFARWRYKVSVTLSGK-K--VTGHILVSLFGNEGNSRQYEIYKGTLQPDNTHSDEFDSDVEVGDLQKVKFIWYNNNVINPTLPRVGASKITVER-NDGKVYDFCSQET 4 horse-1plip 83.3% QLFYLNT-GDASNFARWRYRVDVTLSGK-K--VTGHVLVSLFGNKGNSRQYEIFQGTLKPDNTYSNEFDSDVEVGDLEKVKFIWY-NNVINLTLPKVGASKITVER-NDGSVFNFCSEET 5 myoco-1plip 79.2% QQFYLNT-GDASNFSRWRYQIAVTLSGR-K--VTGHVLVSLYGSGGTSKQYEIYKGSLQPGTSYVNQIDSDVDVGDIEKVKFIWY-NNIINPTLPKVGASSIQVTR-NDGRVFNFCSQDT 6 mouse-1plip 78.5% QTFYLNT-GDKSNFARWRYQVTVTLSGQ-K--VTGHILVSLFGNGGNSKQYEVFKGSLQPGTSHVNEFDSDVDVGDLQKVKFIWY-NNVINPTLPKVGASRITVER-NDGRVFNFCSQET 7 ratno-1plip 78.1% QKFYLNT-GDKSNFARWRYQVTVTLSGQ-K--VTGHILVSLFGNGGNSKQYEVFKGSLHPGDTHVKEFDSDMDVGDLQKVKFIWY-NNVINPTLPKVGASRISVER-NDGRVFNFCSQDT 8 cavpo-1plip 75.9% QNFYLNT-GDKSNFSRWRYRIAVTLSGQ-K--VTGHVLVSLFGDAGNTKQYEIYRGSLKPGNNHSNEIDSDVDVGDLQKVKFIWY-NNVINITLPKVGASRITVTR-SDGRVFDFCSQDT 9 rabit-1plip 79.6% QTFYLNT-GDSSNFARWRYQVAVTLSGR-R--VTGHVLVSLYGSKGNSKQYEIFTGLLKPGDTHLNEFDSDVDVGDVQKVKFVWY-NNVINPTLPKVGASQITVEQ-NDGRVFKFCSTDT 10 human-PNLIPRP1 67.1% QKFFLNT-GEASNFARWRYGVSITLSGR-T--ATGQIKVALFGNKGNTHQYSIFRGILKPGSTHSYEFDAKLDVGTIEKVKFLWN-NNVINPTLPKVGATKITVQKGEEKTVYNFCSEDT 11 canfa-1plip 68.4% QKYFLNT-GDSSNFARWRYGVSITLSGK-R--ATGQAKVALFGSKGNTHQFNIFKGILKPGSTHSNEFDAKLDVGTIEKVKFLWN-NNVVNPTFPKVGAAKITVQKGEEKTVHSFCSEST 12 mouse-1plrp 65.8% QKFFLNT-GEAKNFARWRYRVSLTFSGR-T--VTGQVKVSLFGSNGNTRQCDIFRGIIKPGATHSNEFDAKLDVGTIEKVKFLWN-NHVVNPSFPKVGAAKITVQKGEERTEHNFCSEET 13 ratno-3plip 66.5% QKFFLNT-GEAKNFARWRYRVSLILSGR-M--VTGQVKVALFGSKGNTRQYDIFRGIIKPGATHSSEFDAKLDVGTIEKVKFLWN-NQVINPSFPKVGAAKITVQKGEERTEYNFCSEET 14 human-PNLIPRP2 64.0% QTFFLNT-GESGNFTSWRYKVSVTLSGKEK--VNGYIRIALYGSNENSKQYEIFKGSLKPDASHTCAIDVDFNVGKIQKVKFLWN-KRGINLSEPKLGASQITVQSGEDGTEYNFCSSDT 15 ratno-4plip 65.6% QTVYLNT-GDSGNFTRWRYKVSVTLSGAKK--LSGYILVALYGNNGNSKQYEIFKGSLKPEARHVRDIDVDINVGEIQKVKFLWN-NKVINLFRPTLGASQITVQSGVDGKEYNFCSSDT 16 mouse-cttli 66.2% QTFFLNT-ADTGNFTRWRYKVSVTLSGPKK--LSGYILVALYGCNANSKQYEVFKGSLQPEARYIRDIDVDVNVGEIQKVKFLWN-NKVINLFRPTMGASQITLQRAKDGKEFNFCTSNT 17 bovin-lipr2 61.2% QTFFLNT-GSSGNFTSWRYRVSVTLAGTKK--VRGSIRIALYGSNGNSKQYQIFKGSLQPNASHTHDIDVDLNVGKVQKVKFLWN-NNVINLFWPKLGASRVTVQGGEDRTEYNFCSNDT 18 myoco-2plrp 63.0% KTYFLNT-GDSDNFPRWRYKVSVTLSGEKE--LSGDIKIALFGRNGNSKQYEIFKGSLKPDARYTHDIDVDLNVGEIQKVKFLWH-NNGINLLQPKLGASQITVQSGEYGTKYNFCSSNT 19 horse-2plrp 57.7% QTFFLNT-GESGDYTSWRYRVSITLAGSGK--ANGYLKVTLRGSNGNSKQYEIFKGSLQPDSSYTLDVDVNFIIGKIQEVKFVWN-KTVLNLSKPQLGASRITVQSGADGTEYKFCGSGT 20 xenla-q4klb6 65.2% QKFFLNT-GDEKDFARWRYRVTVQITSSSD--VQGYFHVSLYGVNGNTRQYEIYKGTLKSGSSYTGFIDVESDVGILDKVKFVWN-NNVINILLPTVGAQSISVQYGKDGRTYRFCGSGS 21 xenla-q642r3 53.4% HSYFLNT-GSEKPYSRWRYRVTVKTTGRLN--FFGSIQVSLHGVKGSTTGQEIARRLIKPGQTYTAFIDVEADVGPLTTVSFSWN-KSLIDIIPSKVGAEMISVQYGKDGQTYKFCGKDT 22 xentr-q6p2z1 55.1% YSYFLNT-GSEKPYSRWRYRVTVKTTGSVN--FLGSVQVLLNGIKGSTKGEEIASGFIKPGSTYSAFIDVEADVGPLITVSFTWK-KSLINLIPFTVGAEMITVQYGKDGQTYEFCGKDA 23 xentr-q5eb42 52.6% LSFFLNT-GNSEPFARWRYRVTVRTTGT-G--FLGSIQVSLHGIRGNSKQQEIASGFIKPGGTYSAFIDTESDVGPLTTASFTWK-KSLIDLIPGTVGADTVTVQYGKDGQTYHFCSTET 24 angja-1plip 57.7% MKFYLNT-ADAKPFGRYRYKVTVTIRADRALLLTGTMSVAIYGTQGNTRQYQIRKGLLKPGNTYEAYIDTETDAGEVTKMKFIWD-NSVINPMFPKLGAEKIVLQRGKDRRIFSFCSSET 25 xenla-q6pad5 45.5% QTFYLNTGGNISHFSNWRYKVSVTLGGTKT--FKGKFYVILSATGGDPQQYEVVSKSLIPGNNFSGFIDVGFELGPLDDVTCKWE-PAFLNIFHDQFGAQRLEIQSGKDGKVSTFCGKGT 26 human-PNLIPRP3 46.7% SHYFLNT-GSLSPFARWRHKLSVKLSGSEV--TQGTVFLRVGGAVRKTGEFAIVSGKLEPGMTYTKLIDADVNVGNITSVQFIWK-KHLFEDSQNKLGAEMVINTSGKYGYKSTFCSQDI consensus/100% ..haLsT.up.t.asphRatlsl.htu.....h.G.h.l.l.u..tpstt.tlhpt.l.st.pa...hDst..hG.l..hph.W...thhp....phGAt.l..p....t...pFCs.t. consensus/90% .paaLNT.GpttsaspWRYplslphsGp.t..h.G.h.ltLhG.tusopp.plhpG.lpPstpa.t.hDschplG.lppVpFhW..pphls...sphGAt.l.lp..p.tp.apFCupto consensus/80% ppaaLNT.GstpsFsRWRYpVoVploGp.p..hpGplhVuLaGstGNo+Qa-IhpG.LpPssoast.hDschsVGplpcVKFlW..pplIN...PplGAppIoVpp.p-tp.apFCoppT consensus/70% QpFaLNT.G-tssFuRWRY+VoVTLoGp.p..hsGplhVuLaGspGNo+QYEIa+G.LcPssoaotthDs-h-VGplp+VKFlW..NslIN.hhP+lGAspIoVpp.pDGp.asFCSp-T 1 human-PNLIP 100.0% VREEVLLTLTPC------ 2 spetr-1plip 84.7% VREDVLLTLNAC------ 3 sussc-1plip 85.3% VREEVLLTLNPC------ 4 horse-1plip 83.3% VREDVLLTLTAC------ 5 myoco-1plip 79.2% VREDILLTLTPC------ 6 mouse-1plip 78.5% VREDVLLTLSPC------ 7 ratno-1plip 78.1% VREDVLLTLSAC------ 8 cavpo-1plip 75.9% VREEVLLTLQPC------ 9 rabit-1plip 79.6% VREDILLTLTPC------ 10 human-PNLIPRP1 67.1% VREDTLLTLTPC------ 11 canfa-1plip 68.4% VREDVLLTLTPC------ 12 mouse-1plrp 65.8% VREDILLTLLPCKTSDTM 13 ratno-3plip 66.5% VREDTLLTLLPCETSDTV 14 human-PNLIPRP2 64.0% VEENVLQSLYPC------ 15 ratno-4plip 65.6% VREDVLQSLYPC------ 16 mouse-cttli 66.2% VHEDVLQSLYPC------ 17 bovin-lipr2 61.2% MRENALQTLYPC------ 18 myoco-2plrp 63.0% VQEDVLQSLSPC------ 19 horse-2plrp 57.7% VQDNVEQSLYPC------ 20 xenla-q4klb6 65.2% VREEVLQTLNAC------ 21 xenla-q642r3 53.4% VRAKSLQSLTSCSSATK- 22 xentr-q6p2z1 55.1% VRPNNLQSLTSCYSATK- 23 xentr-q5eb42 52.6% VKPKTIQNLTPCYIPDE- 24 angja-1plip 57.7% VREEMLQTVPPC------ 25 xenla-q6pad5 45.5% VSENVLQKLIPC------ 26 human-PNLIPRP3 46.7% MGPNILQNLKPC------ consensus/100% ht.p...pl.sC...... consensus/90% Vp.phL.sL.sC...... consensus/80% V+EpsL.oL.sC...... consensus/70% VREclL.oL.PC...... |
MView 1.56, Copyright © 1997-2013 Nigel P. Brown